Author:
Cerveny C G,Law C-L,McCormick R S,Lenox J S,Hamblett K J,Westendorf L E,Yamane A K,Petroziello J M,Francisco J A,Wahl A F
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference37 articles.
1. Skinnider BF, Elia AJ, Gascoyne RD, Trumper LH, Bonin FV, Kapp U et al. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed–Sternberg cells of Hodgkin lymphoma. Blood 2001; 97: 250–255.
2. Leroy X, Augusto D, Leteurtre E, Gosselin B . CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J Histochem Cytochem 2002; 50: 283–285.
3. Gruss H-J, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG . Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994; 83: 2045–2056.
4. Pinto A, Aldinucci D, Gloghini A, Zagonel V, Degan M, Improta S et al. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line. Blood 1996; 88: 3299–3305.
5. Wahl AF, Klussman K, Thompson JD, Chen JH, Francisco LV, Risdon G et al. The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease. Cancer Res 2002; 62: 3736–3742.
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献